Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy

International Journal of Cardiology

Volumn 223, Issue , 2016, Pages 574-580

  Giannini, Cristina ^a   Fiorelli, Francesca ^a   Colombo, Antonio ^b   De Carlo, Marco ^a   Weisz, Sara Hana ^c   Agricola, Eustachio ^b   Godino, Cosmo ^b   Castriota, Fausto ^d   Golino, Paolo ^c   Petronio, Anna Sonia ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d MARIA CECILIA HOSPITAL   (Italy)

Author keywords

Percutaneous mitral valve repair

Indexed keywords

AGE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMORBIDITY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CLIP; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; PERCUTANEOUS MITRAL VALVE REPAIR; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL RISK; SURVIVAL RATE; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING; TREATMENT OUTCOME; DIAGNOSTIC IMAGING; HEART RIGHT VENTRICLE FUNCTION; HEART VALVE REPLACEMENT; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MORTALITY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SURGICAL EQUIPMENT; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; SURGICAL INSTRUMENTS; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, RIGHT;

EID: 84982313700     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.08.189     Document Type: Article

References (36)

1. [1] Levine, R.A., Schwammenthal, E., Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 112 (2005), 745–758.
2. [2] Agricola, E., Ielasi, A., Oppizzi, M., Faggiano, P., Ferri, L., Calabrese, A., et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur. J. Heart Fail. 11 (2009), 581–587.
3. [3] Swaans, M.J., Bakker, A.L., Alipour, A., Post, M.C., Kelder, J.C., de Kroon, T.L., et al. Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. JACC Cardiovasc. Interv. 7 (2014), 875–881.
4. [4] Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J. Am. Coll. Cardiol. 62 (2013), 1052–1061.
5. [5] Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M.J., Barón-Esquivias, G., Baumgartner, H., et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. J. Cardiothorac. Surg. 42 (2012), S1–44.
6. [6] Nishimura, R.A., Otto, C.M., Bonow, R.O., Carabello, B.A., Erwin, J.P., Guyton, R.A., et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 (2014), e521–e643.
7. [7] Franzen, O., Baldus, S., Rudolph, V., Meyer, S., Knap, M., Koschyk, D., et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur. Heart J. 31 (2010), 1373–1381.
8. [8] Pleger, S.T., Schulz-Schönhagen, M., Geis, N., Mereles, D., Chorianopoulos, E., Antaredja, M., et al. One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip(C) implantation. Eur. J. Heart Fail., 2013.
9. [9] Whitlow, P.L., Feldman, T., Pedersen, W.R., Lim, D.S., Kipperman, R., Smalling, R., et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J. Am. Coll. Cardiol. 59 (2012), 130–139.
10. [10] D'ascenzo, F., Moretti, C., Marra, W.G., Montefusco, A., Omede, P., Taha, S., et al. Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am. J. Cardiol. 116 (2015), 325–331.
11. [11] Giannini, C., Fiorelli, F., De Carlo, M., Guarracino, F., Faggioni, M., Giordano, P., et al. Comparison of Percutaneous Mitral Valve Repair Versus Conservative Treatment in Severe Functional Mitral Regurgitation. Am. J. Cardiol., 2015.
12. [12] Giannini, C., Petronio, A.S., De Carlo, M., Guarracino, F., Conte, L., Fiorelli, F., et al. Integrated reverse left and right ventricular remodelling after MitraClip implantation in functional mitral regurgitation: an echocardiographic study. Eur. Heart J. Cardiovasc. Imaging 15 (2014), 95–103.
13. [13] Glower, D.D., Kar, S., Trento, A., Lim, D.S., Bajwa, T., Quesada, R., et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J. Am. Coll. Cardiol. 64 (2014), 172–181.
14. ® therapy in patients with end-stage systolic heart failure. Eur. J. Heart Fail. 13 (2011), 569–576.
15. [15] Rudolph, V., Huntgeburth, M., von Bardeleben, R.S., Boekstegers, P., Lubos, E., Schillinger, W., et al. Clinical outcome of critically ill, not fully recompensated, patients undergoing MitraClip therapy. Eur. J. Heart Fail. 16 (2014), 1223–1229.
16. [16] Taramasso, M., Denti, P., Buzzatti, N., De Bonis, M., La Canna, G., Colombo, A., et al. Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience. Eur. J. Cardiothorac. Surg. 42 (2012), 920–926.
17. [17] Neuss, M., Schau, T., Schoepp, M., Seifert, M., Hölschermann, F., Meyhöfer, J., et al. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur. J. Heart Fail., 2013.
18. [18] de Groote, P., Fertin, M., Goéminne, C., Petyt, G., Peyrot, S., Foucher-Hossein, C., et al. Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters. Eur. Heart J. 33 (2012), 2672–2679.
19. [19] Kjaergaard, J., Akkan, D., Iversen, K.K., Køber, L., Torp-Pedersen, C., Hassager, C., Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure. Eur. J. Heart Fail. 9 (2007), 610–616.
20. [20] Damy, T., Viallet, C., Lairez, O., Deswarte, G., Paulino, A., Maison, P., et al. Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure. Eur. J. Heart Fail. 11 (2009), 818–824.
21. [21] Attizzani, G.F., Ohno, Y., Capodanno, D., Cannata, S., Dipasqua, F., Immé, S., et al. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. JACC Cardiovasc. Interv. 8 (2015), 74–82.
22. [22] Feldman, T., Wasserman, H.S., Herrmann, H.C., Gray, W., Block, P.C., Whitlow, P., et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J. Am. Coll. Cardiol. 46 (2005), 2134–2140.
23. [23] Feldman, T., Foster, E., Glower, D.D., Glower, D.G., Kar, S., Rinaldi, M.J., et al. Percutaneous repair or surgery for mitral regurgitation. N. Engl. J. Med. 364 (2011), 1395–1406.
24. [24] Horton, K.D., Meece, R.W., Hill, J.C., Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. J. Am. Soc. Echocardiogr. 22 (2009), 776–792 (quiz 861-2).
25. [25] Lang, R.M., Badano, L.P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28 (2015), 1–39, e14.
26. [26] Lancellotti, P., Tribouilloy, C., Hagendorff, A., Popescu, B.A., Edvardsen, T., Pierard, L.A., et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging 14 (2013), 611–644.
27. ® procedure. Anesth. Analg. 118 (2014), 1188–1196.
28. [28] Puls, M., Lubos, E., Boekstegers, P., von Bardeleben, R.S., Ouarrak, T., Butter, C., et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur. Heart J., 2015.
29. [29] Boerlage-vanDijk, K., Wiegerinck, E.M., Araki, M., Meregalli, P.G., Bindraban, N.R., Koch, K.T., et al. Predictors of outcome in patients undergoing MitraClip implantation: An aid to improve patient selection. Int. J. Cardiol. 189 (2015), 238–243.
30. [30] Nickenig, G., Estevez-Loureiro, R., Franzen, O., Tamburino, C., Vanderheyden, M., Lüscher, T.F., et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. J. Am. Coll. Cardiol. 64 (2014), 875–884.
31. [31] Schueler, R., Nickenig, G., May, A.E., Schillinger, W., Bekeredjian, R., Ouarrak, T., et al. Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function. EuroIntervention, 11, 2015.
32. [32] le Tourneau, T., Right ventricle impairment: are we changing the paradigm in organic mitral regurgitation?. Arch. Cardiovasc. Dis. 106 (2013), 419–422.
33. [33] Ghio, S., Recusani, F., Klersy, C., Sebastiani, R., Laudisa, M.L., Campana, C., et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am. J. Cardiol. 85 (2000), 837–842.
34. [34] Dini, F.L., Conti, U., Fontanive, P., Andreini, D., Banti, S., Braccini, L., et al. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am. Heart J. 154 (2007), 172–179.
35. [35] Beaudoin, J., Levine, R.A., Guerrero, J.L., Yosefy, C., Sullivan, S., Abedat, S., et al. Late repair of ischemic mitral regurgitation does not prevent left ventricular remodeling: importance of timing for beneficial repair. Circulation 128 (2013), S248–S252.
36. [36] Chung, R., Percutaneous Mitral Valve Intervention and modelling with multi-modality imaging. Int. Cardiovasc. Forum J. 1 (2014), 117–121.